none15noneBolondi L.; Piscaglia F.; Gatta A.; Salerno F.; Bernardi M.; Ascione A.; Ferrau O.; Sacerdoti D.; Visentin S.; Trevisani F.; Mazzanti R.; Donati G.; Arena U.; Gentilini P.; DOC (Decrease of Complications in cirrhosis) Study Group.Bolondi L.; Piscaglia F.; Gatta A.; Salerno F.; Bernardi M.; Ascione A.; Ferrau O.; Sacerdoti D.; Visentin S.; Trevisani F.; Mazzanti R.; Donati G.; Arena U.; Gentilini P.; DOC (Decrease of Complications in cirrhosis) Study Group
The use of paracentesis has recently been reproposed as a safe and effective alternative to diuretic...
BACKGROUND: There is little information on the effects of vaptans in patients with cirrhosis. AIM: ...
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients wi...
Background & Aims: Because aldosterone-dependent sodium and water retention contribute to portal hyp...
BACKGROUND & AIMS: Because aldosterone-dependent sodium and water retention contribute to portal hyp...
BACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrh...
Objective: To evaluate the factors leading to hyperkalemia in patients with cirrhosis receiving spi...
Introduction: Large-volume paracentesis is one of the usual treatments for cirrhotic patients with t...
fibrotic tissue altersportal blood flow and resistance, lead-ing to portal hypertension and activati...
OBJECTIVE: The aim of the study was to compare sequential versus combined diuretic therapy in patien...
Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates asc...
This controlled study in cirrhotic patients investigated whether two antialdosteronic steroids, spir...
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's dis...
none38mixedGinès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F; NormoCAT study investiga...
Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with comp...
The use of paracentesis has recently been reproposed as a safe and effective alternative to diuretic...
BACKGROUND: There is little information on the effects of vaptans in patients with cirrhosis. AIM: ...
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients wi...
Background & Aims: Because aldosterone-dependent sodium and water retention contribute to portal hyp...
BACKGROUND & AIMS: Because aldosterone-dependent sodium and water retention contribute to portal hyp...
BACKGROUND/AIMS: Aldosterone antagonists are the diuretics of first choice in the treatment of cirrh...
Objective: To evaluate the factors leading to hyperkalemia in patients with cirrhosis receiving spi...
Introduction: Large-volume paracentesis is one of the usual treatments for cirrhotic patients with t...
fibrotic tissue altersportal blood flow and resistance, lead-ing to portal hypertension and activati...
OBJECTIVE: The aim of the study was to compare sequential versus combined diuretic therapy in patien...
Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates asc...
This controlled study in cirrhotic patients investigated whether two antialdosteronic steroids, spir...
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's dis...
none38mixedGinès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F; NormoCAT study investiga...
Ascites is the most common cause of decompensation in cirrhosis, and 5% to 10% of patients with comp...
The use of paracentesis has recently been reproposed as a safe and effective alternative to diuretic...
BACKGROUND: There is little information on the effects of vaptans in patients with cirrhosis. AIM: ...
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients wi...